ATF3 and breast cancer: It has been demonstrated that when CTLA-4+ breast cancer cells and human dendritic cells (DCs) are cocultured, the extracellular signal-regulated kinase and activating transcription Factor 3 (ATF3) of DCs are inhibited, thus suppressing the function and maturation of DCs (16).